Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
European Journal of Human Genetics : EJHG|March 29, 2012
The changing landscape of genetic testing and its impact on clinical and laboratory services and research in EuropeRos Hastings, Guido de Wert, Brian Fowler, et al.Reproductive Biology and Endocrinology : RB&E|March 10, 2010
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control studyOlaf Sunnotel, Laszlo Hiripi, Kevin Lagan, et al.JAMA|August 10, 2002
Sertraline treatment of major depression in patients with acute MI or unstable anginaAlexander H Glassman, Christopher M O'Connor, Robert M Califf, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 6, 2010
Benchmarks for cystic fibrosis carrier screening: a European consensus documentCarlo Castellani, Milan Macek, Jean-Jacques Cassiman, et al.The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.Community Genetics|June 19, 2007
Report of an international survey of molecular genetic testing laboratoriesMargaret M McGovern, Rob Elles, Isabella Beretta, et al.The British Journal of Psychiatry : the Journal of Mental Science|July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS studyNick Glozier, Richard Morris, Elizabeth Stratton, et al.JAMA Neurology|November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical TrialScott Ayton, David Barton, Bruce Brew, et al.The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.Pageof 10